Risky business: Diabetic Clinical Trial Ends Abruptly
Late last year Novartis announced termination of ALTITUDE study with Rasilez®/ Tekturna® in high-risk patients with diabetes and renal impairment; 8,609 patients from 36 countries were involved.
Posts Tagged ‘fda testing’
Backlogged FDA: Will More Scientists Shrink Backlog of Applications?
The FDA has dipped into the $10 million allocated to the Office of Generic Drugs for this fiscal year to hire 50 more scientists in hopes of shrinking the backlog of around 2,000 applications that are already awaiting review.
